Chromadex Corp (CDXC)

NASDAQ
8.93
+0.20(+2.29%)
After Hours
8.93
0.00(0.00%)
- Real-time Data
  • Volume:
    398,286
  • Bid/Ask:
    8.80/9.06
  • Day's Range:
    8.60 - 9.06

CDXC Overview

Prev. Close
8.73
Day's Range
8.6 - 9.06
Revenue
59.27M
Open
8.8
52 wk Range
3.82 - 23.62
EPS
-0.33
Volume
398,286
Market Cap
606.64M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
3,957,863
P/E Ratio
-
Beta
1.68
1-Year Change
67.54%
Shares Outstanding
67,932,548
Next Earnings Date
May 06, 2021
What is your sentiment on Chromadex Corp?
or
Market is currently closed. Voting is open during market hours.

Chromadex Corp News

Chromadex Corp Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsBuyBuyStrong BuyBuyStrong Buy
SummaryBuyStrong BuyStrong BuyStrong BuyStrong Buy

Chromadex Corp Company Profile

Chromadex Corp Company Profile

Employees
110

Chromadex Corporation is an integrated nutraceutical company. The Company and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provides research and quality-control products and services to the natural products industry. The Company partners with universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of nicotinamide adenine dinucleotide (NAD) and its impact on human health. The Company’s operated segments are: Consumer Product, Ingredients, and Analytical Reference Standards and Service Segment. Its Consumer Product segment offers TRU NIAGEN to consumers worldwide. Its ingredients business segment develops and commercializes ingredients, including nicotinamide riboside (NR), for which its brand name is NIAGEN. It also develops pterostilbene, which is marketed and sold under its brand name, pTeroPure.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.